Manmeet Ahluwalia, Chief Scientific Officer, Chief of Medical Oncology, and Deputy Director of Miami Cancer Institute, Baptist Health South Florida, shared a post on LinkedIn:
“It is a privilege to serve as the Program Chair of 4th Baptist Health Miami Cancer Institute Precision Oncology Symposium!
It has been exhilarating over the last 2 decades to the see the improvement in the outcomes of the cancer patients due to premise of the Precision Oncology- matching the right drug to the patient: the basis of Precision Medicine.
The advent of Novel targeted therapies, Immunotherapies and Antibody drug conjugates has transformed the cancer care and outcomes. For the first time ever, 70% of patients now live five years after their cancer diagnosis, according to the American Cancer Society annual report.
Look forward to a stellar line of speakers and learning over next two days in Miami at the Loews Hotels and Co, Coral Gables.”
More posts featuring Manmeet Ahluwalia on OncoDaily.
